Back to search

Article

Immunohistochemistry based molecular subtyping of pancreatic neuroendocrine tumor correlates with clinicopathological outcome: A single institute retrospective study

2022-09-27

Abstract excerpt

<h4>Purpose: </h4> Pancreatic neuroendocrine tumors (PanNETs) account for ~3-4% of all pancreatic tumors worldwide. The WHO grading and TNM staging in PanNET do not accurately predict the clinical behaviour and prognosis. <h4>Methods: </h4> In this single institute retrospective study, cases of PanNETs were selected. Immunohistochemistry (IHC) for ATRX, DAXX, Menin, ARX and PDX-1 markers were performed on formali...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ed999c3a-ebeb-5718-b1fb-37883270ab30
DOI
10.21203/rs.3.rs-2088495/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunohistochemistry based molecular subtyping of pancreatic neuroendocrine tumor correlates with clinicopathological outcome: A single institute retrospective studyDOI 10.21203/rs.3.rs-2088495/v1
Select a neighboring publication to make it the new centre.